Heart stem cells show promise in kids with half a heart
NCT ID NCT03406884
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether injecting a child's own heart stem cells during a planned surgery could help their heart work better. It involved 25 children with hypoplastic left heart syndrome, a condition where the left side of the heart is underdeveloped. The main goals were to see if the procedure was safe and possible, and to check for any improvements in heart function over a year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOPLASTIC LEFT HEART SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611, United States
-
Emory University Children's Healthcare of Atlanta - Egleston Campus
Atlanta, Georgia, 30322, United States
-
Michigan Medicine Congenital Heart Center/C.S. Mott Children's Hospital
Ann Arbor, Michigan, 48109, United States
-
University of Maryland - Division of Cardiac Surgery
Baltimore, Maryland, 21201, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fetal heart surgery could change life for babies with Half-Formed hearts
- Blood protein test could predict Post-Surgery risks in kids with heart defects
- New app aims to ease Parents' stress over Baby's heart surgery decision
- Moms' stress in pregnancy linked to baby brain outcomes in heart defect study
- Heart defect study tracks kids' outcomes 11 years after surgery
- Could a child's own stem cells strengthen a weak heart after surgery?